BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

Cancer immunotherapy: Special issue of BMB Reports in 2021
Eui-Cheol Shin1,* (Professor)
1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea
Basically, cancer is a disease initiated by mutations in the genome. However, cancer is regarded not only as a genetical disease but also an immunological disease because cancer cells can be targeted by the immune system. The immune system recognizes mutated proteins as non-self, foreign antigens, so-called neoantigens, and exerts diverse effector functions to eliminate tumor cells. Anti-tumor immune responses resemble immune responses against viruses. In anti-tumor immune responses, CD8+ and CD4+ T cells are the main effector cells. In addition, dendritic cells (DCs) play a crucial role in the priming of CD8+ and CD4+ T cells, and natural killer (NK) cells also contribute to the anti-tumor immune responses.
Abstract, Accepted Manuscript [Submitted on January 6, 2021, Accepted on January 6, 2021]
  Copyright © KSBMB. All rights reserved. / Powered by INFOrang Co., Ltd